Barash Oleksii O, Ivani Kristen A, Willman Susan P, Rosenbluth Evan M, Wachs Deborah S, Hinckley Mary D, Pittenger Reid Sara, Weckstein Louis N
Reproductive Science Center of the San Francisco Bay Area, 100 Park Place, Suite 200, San Ramon, CA, 94583, USA.
J Assist Reprod Genet. 2017 Aug;34(8):1007-1016. doi: 10.1007/s10815-017-0944-0. Epub 2017 May 30.
The purpose of the present study is to examine interconnection between speed of embryo development, the genetic status of the blastocysts, and clinical outcomes in IVF preimplantation genetic screening (PGS) cycles with single embryo transfer (SET).
The retrospective comparative study has been performed between January 2013 and January 2016. Seven hundred thirty-seven cycles of IVF treatment with PGS, followed by 503 SETs, were included in the study. Normally fertilized oocytes were hatched on day 3, were cultured to the blastocyst stage, and were biopsied only when at least three to seven cells were herniating from zona pellucida on the morning of day 5 (≤118 h) or day 6 (≥139 h). A total of 3705 embryos were analyzed for euploidy rates and blastocyst morphology. All embryos were vitrified after the biopsy, and selected embryos were subsequently thawed for a hormone replacement frozen embryo transfer cycle.
The euploidy rate was significantly higher among embryos biopsied on day 5 versus day 6: 59.44 ± 4.1 and 48.19 ± 3.8, respectively, p < 0.05. The difference in euploidy rates between embryos biopsied on day 5 versus day 6 in matched age groups increased from 5.83 to 25.46% with advancing maternal age. Our data demonstrated no statistically significant difference in euploidy rates between good-quality embryos biopsied on day 5 in the group of patients <38 years old and embryos in PGS cycles using donor oocytes: 71.12% (336/472) and 75.68% (221/292), respectively, p = 0.174, χ = 1.848. In 270 out of 503 SETs, transferred embryos were biopsied on day 5 (ongoing pregnancy rate was 64.6% in a group of patients <38 years old, and in a group of patients ≥38 years old, ongoing PR was 64.2%). In 233 out of 503 cycles, transferred embryos were biopsied on day 6 (ongoing PR was 46.6% in a group of patients <38 years old, and in a group of patients ≥38 years old, ongoing PR was 50.8%). In all study groups, the ongoing pregnancy rate was higher when the transferred embryo was available for biopsy on day 5.
Good- and fair-quality embryos available for biopsy on day 5 have higher euploidy rates and have a higher chance to result in an ongoing pregnancy. Euploidy rate has significant variations within the same age group depending on the morphology of the blastocysts.
本研究旨在探讨体外受精单胚胎移植(SET)的植入前遗传学筛查(PGS)周期中胚胎发育速度、囊胚的遗传状态与临床结局之间的相互联系。
在2013年1月至2016年1月期间进行了一项回顾性比较研究。该研究纳入了737个接受PGS的体外受精治疗周期,随后进行了503次单胚胎移植。正常受精的卵母细胞在第3天孵化,培养至囊胚期,仅在第5天(≤118小时)或第6天(≥139小时)早晨至少有三到七个细胞从透明带疝出时进行活检。共分析了3705个胚胎的整倍体率和囊胚形态。所有胚胎在活检后进行玻璃化冷冻,随后选择的胚胎解冻用于激素替代冷冻胚胎移植周期。
第5天活检的胚胎整倍体率显著高于第6天活检的胚胎:分别为59.44±4.1和48.19±3.8,p<0.05。随着母亲年龄的增长,匹配年龄组中第5天与第6天活检的胚胎整倍体率差异从5.83%增加到25.46%。我们的数据表明,在<38岁患者组中第5天活检的优质胚胎与使用供体卵母细胞的PGS周期中的胚胎整倍体率无统计学显著差异:分别为71.12%(336/472)和75.68%(221/292),p = 0.174,χ = 1.848。在503次单胚胎移植中的270次中,移植的胚胎在第5天进行活检(<38岁患者组的持续妊娠率为64.6%,≥38岁患者组的持续妊娠率为64.2%)。在503个周期中的233次中,移植的胚胎在第6天进行活检(<38岁患者组的持续妊娠率为46.6%,≥38岁患者组的持续妊娠率为50.8%)。在所有研究组中,当移植的胚胎在第